We Are Shipping Australia, USA, UK and Europe , Russia.
| PACK SIZE | PRICE | PER UNIT | |
|---|---|---|---|
| 1 Bottle (15 capsules) | $ 25.00 | $ 28.00 | Add To Cart |
| 2 Bottle (30 Capsules) | $ 50.00 | $ 26.00 | Add To Cart |
| 4 Bottle (60 Capsules) | $ 90.00 | $ 24.00 | Add To Cart |
| 8 Bottle (120) | $ 170.00 | $ 22.00 | Add To Cart |
Triohale Rotacaps contain a synergistic triple-combination maintenance formulation typically combining an Inhaled Corticosteroid (ICS), a Long-Acting Beta2-Agonist (LABA), and a Long-Acting Muscarinic Antagonist (LAMA) designed for step-up long-term maintenance control in severe persistent asthma or chronic obstructive pulmonary disease (COPD) inadequately controlled by dual therapy. At Alldays Medicine, order authentic Triohale Rotacaps online across Australia with flexible multi-pack savings, verified prescription compliance, secure checkout, and discreet doorstep dispatch.
| Attribute | Detail |
| Active Pharmacological Class | Triple Combination Therapy (ICS + LABA + LAMA Maintenance Controller) |
| Primary Indication | Long-term maintenance treatment of severe persistent asthma / COPD |
| Product Code / SKU | 7589579 |
| Pack Base Unit | 1 Bottle (15 Dry Powder Inhalation Capsules) |
| Manufacturer / Origin | Cipla |
| Delivery Scope | Australia-wide (Sydney, Melbourne, Brisbane, Perth, Adelaide, regional hubs) |
| Pack Option | Total Price (AUD) | Effective Unit Value |
| 1 Bottle (15 Capsules) | $25.00 | $1.67 / capsule base tier |
| 2 Bottles (30 Capsules) | $50.00 | $1.67 / capsule standard tier |
| 4 Bottles (60 Capsules) | $90.00 | $1.50 / capsule value tier |
| 8 Bottles (120 Capsules) | $170.00 | $1.42 / capsule bulk tier |
Inhaled Corticosteroid (ICS): Suppresses chronic mucosal eosinophilic and neutrophilic airway inflammation, reducing bronchial hyperresponsiveness.
Long-Acting Beta2-Agonist (LABA - e.g., Formoterol component): Sustained 12-hour bronchodilation via bronchial smooth muscle relaxation.
Long-Acting Muscarinic Antagonist (LAMA): Prolonged blockade of M3 muscarinic receptors preventing cholinergic vagal bronchoconstriction and excessive mucus secretion.
Role: Daily maintenance controller only—not for acute rescue. A short-acting SABA reliever (e.g., salbutamol/duolin) must remain accessible for acute bronchospasm episodes.
Load: Place one capsule into the designated chamber of the rotahaler/dry powder device as instructed.
Pierce: Twist/pierce the capsule once to puncture the shell (per device-specific operational guide).
Inhale: Exhale completely away from the device, seal lips tightly around the mouthpiece, and breathe in rapidly and deeply.
Hold & Repeat: Remove device, hold breath for 10 seconds, then exhale. Check capsule chamber to ensure powder delivery.
Oral Hygiene: Rinse mouth thoroughly with water and spit out (do not swallow) after inhalation to prevent oral thrush/candidiasis.
Prescription Requirement: Scheduled maintenance anti-asthmatic medication; valid Australian prescription or telehealth verification mandatory.
Not for Acute Exacerbations: Do not use Triohale for acute severe asthma attacks or sudden onset wheezing.
Cardiovascular & Systemic Monitoring: LABA/LAMA components require caution in severe cardiovascular disease, narrow-angle glaucoma, prostatic hyperplasia, or urinary retention.
Complete Daily Adherence: Use strictly as scheduled in your written Asthma/COPD Action Plan, even during symptom-free periods.
Q: Do I need a prescription to buy Triohale Rotacaps online in Australia?
A: Yes. Triohale is a scheduled prescription/telehealth-verified combination therapy. Upload your valid Australian prescription during checkout at Alldays Medicine.
Q: Is Triohale used as a rescue inhaler during an attack?
Y: No. Triohale is a maintenance controller capsules regimen. Acute symptoms require your short-acting rescue inhaler.
Q: Do I need to rinse my mouth after using Triohale Rotacaps?
A: Yes. Rinsing and spitting out water after inhalation clears corticosteroid residue from the throat, lowering the risk of fungal thrush.
Clinical Disclaimer: Dosage adjustments and treatment maintenance tiers must align with the written Action Plan provided by your Australian General Practitioner (GP) or respiratory specialist.
